Home
About
Publications Trends
Recent Publications
Expert Search
Archive
jaundice
What Are the Treatment Options for Jaundice in Cancer Patients?
Treatment of jaundice in cancer patients focuses on addressing the underlying cause, which is often the cancer itself. Potential treatments include:
Surgery
: To remove tumors that are obstructing the bile ducts.
Chemotherapy
or
Radiation Therapy
: To shrink tumors.
Stent Placement
: To keep the bile ducts open.
Liver Transplant
: In severe cases of liver cancer or dysfunction.
Palliative Care
: To manage symptoms and improve quality of life.
Frequently asked queries:
What is Jaundice?
How is Jaundice Related to Cancer?
What Types of Cancer Commonly Cause Jaundice?
What Are the Symptoms of Jaundice in Cancer Patients?
How is Jaundice Diagnosed in Cancer Patients?
What Are the Treatment Options for Jaundice in Cancer Patients?
Can Jaundice Be Prevented in Cancer Patients?
When Should a Cancer Patient Seek Medical Attention for Jaundice?
What Causes Stromal Tumors?
What are AI-Driven Simulations?
How Do Cancer Cells Evade Lymphocytes?
Are There Emerging Concerns?
What Materials Are Used in Sustainable Packaging?
How is Splenic Rupture Related to Cancer?
How Does it Benefit Medical Professionals?
Can Diverticulitis Increase the Risk of Cancer?
Why Are These Populations Underrepresented?
What is Cevimeline?
How Do They Support Emotional Well-being?
Are There Specific Activities to Avoid?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe